The Osteoporosis Exemplary Care Program (OECP) at St. Michael’s Hospital in Toronto, Ontario has been a leader in the FLS movement in Canada and worldwide. OECP was founded in 2002 […]

PRESS RELEASE TORONTO, November 19, 2020 – Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention. Dr. Famida Jiwa, President & CEO, Osteoporosis […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

Important Changes to the Availability and Conditions of Use for Drugs Containing Calcitonin Calcitonin nasal spray for the treatment of osteoporosis is no longer available in Canada because of new […]

About Us Educate, empower and support Who Are We Osteoporosis Canada is the only national organization serving people affected by osteoporosis. The organization works to educate, empower and support individuals […]

Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]

SUPPORT RESOURCES Booklets, Brochures, Fact Sheets and Inserts English Resources Booklets & Fact Sheets Drug Treatments This four-page fact sheet focuses on medications used to treat osteoporosis. Contains detailed information […]

LONG TERM CARE Long Term Care Video Series Osteoporosis Canada, Ontario Osteoporosis Strategy, University of Waterloo and GERAS Centre for Aging Research are excited to announce the launch of four […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]